Amwill Healthcare IPO Day 2: Latest GMP, Subscription Status, Offer Size, Price Band And More
Amwill Healthcare IPO GMP was Rs 6 apiece as of 1:08 p.m. on Feb. 6, as per InvestorGain. This projects a listing gain of 5.41% over the issue price, with the debut price of each share being Rs 117.
Amwill Healthcare launched its IPO on Wednesday to raise nearly Rs 60 crore from the primary market. The SME IPO was subscribed 1.04 times on the opening day, led by demand from Qualified Institutions.
The BSE SME IPO is a combination of a fresh offer of 44.04 lakh shares worth Rs 48.88 crore and an offer for sale of 10 lakh shares amounting to Rs 11 crore.
As the bidding for the second day begins, here are key details that investors must know about Amwill Healthcare IPO:
Amwill Healthcare IPO: All You Need To Know
IPO size: Rs 59.98 crore
Bidding dates: Feb. 5-7
Price band: Rs 105 to Rs 111 per share
Lot size: 1200 shares
Minimum investment: Rs 1,26,000
Share allotment date: Feb. 10
Credit of shares to Demat accounts: Feb. 11
Registrar: Bigshare Services Pvt. Ltd.
Lisitng date: Feb. 12
Amwill Healthcare IPO Subscription Status: Day 2
Amwill Healthcare IPO has been subscribed 1.28 times as of 2:19 p.m. on Thursday, as per the market tracking site Chittorgarh:
Qualified Institutions: 2.19 times
Non-Institutional Investors: 0.46 times
Retail Investors: 1.64 times
*The subscription status will be updated at regular intervals
Amwill Healthcare IPO GMP Today
Amwill Healthcare IPO GMP was Rs 6 apiece as of 1:08 p.m. on Feb. 6, as per InvestorGain. This projects a listing gain of 5.41% over the issue price, with the debut price of each share being Rs 117.
Note: GMP or grey market price is not an official price quote for the stock and is based on speculation.
About Amwill Healthcare IPO
Amwill Healthcare Ltd. is a derma-cosmetic development firm. It makes collaborations with contract manufacturers, distributors, and third-party product development agencies to market its products.
The company makes skin-related products to manage conditions like acne, fungal infections, anti-ageing, histaminic, periorbital hyperpigmentation, scabies, perspiration, trichology and vitiligo.
Amwill Healthcare will use the funds from its IPO to meet working capital needs, engage in marketing and brand-building activities and for general corporate purposes.
Disclaimer: Investments in initial public offerings are subject to market risks. Please consult with financial advisors and read the red herring prospectus thoroughly before placing bids.
